Free Trial

Hamilton Thorne Q3 2023 Earnings Report

Hamilton Thorne logo
C$2.24 0.00 (0.00%)
(As of 12/2/2024 ET)

Hamilton Thorne EPS Results

Actual EPS
-C$0.01
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Hamilton Thorne Revenue Results

Actual Revenue
$21.00 million
Expected Revenue
$22.67 million
Beat/Miss
Missed by -$1.67 million
YoY Revenue Growth
N/A

Hamilton Thorne Announcement Details

Quarter
Q3 2023
Time
N/A

Conference Call Resources

Media Is Mocking Elon, But Wait Until They See This Demo (Ad)

Elon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is not buying it.

Click here to watch this demo and decide for yourself.

Hamilton Thorne Earnings Headlines

Expert: The most important message you’ll see in 2024
The message I'm sharing today could be the most important message of 2024. In short, America is being invaded… The invasion spreading across America is coming from the ports, highways, and railroads.
See More Hamilton Thorne Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Hamilton Thorne? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Hamilton Thorne and other key companies, straight to your email.

About Hamilton Thorne

Hamilton Thorne Ltd. develops, manufactures, and sells precision instruments, laboratory equipment, consumables, software, and services for the assisted reproductive technologies (ART), research, and cell biology markets. The company offers precision laser systems and imaging systems for biology markets. It also provides test laboratory and endotoxin testing services, as well as sperm assays, including Sperm Motility Index and Sperm Penetration; and fresh and cryopreserved mouse embryos supply, and technician training and proficiency testing services. In addition, the company manufactures and distributes medical products for reproductive medicine; manufactures bespoke workstations, incubators, and equipment for IVF laboratories; researches, designs, develops, sells, installs, and services in-vitro diagnostic systems; and manufactures ovum pickup needles, catheters, and other devices. Further, the company offers Cell-Tek Microscope Chamber, a product for controlling temperature, air flow, humidification, and air quality; laminar flow workstations, incubators, and related products; and artificial intelligence enabled CASA software, consumables, and image analysis systems for the ART and laboratory markets, as well as capital equipment and consumables, software, and other services. It sells its products and services under Hamilton Thorne, Gynemed, Planer, Tek-Event, IVFtech, MICROPTIC, Gynétics, and Embryotech brand names through a direct sales force in the United States, Germany, France, Australia, Denmark, Belgium, Spain, and the United Kingdom, as well as through distributors to fertility clinics, hospitals, pharmaceutical companies, biotechnology companies, educational institutions, and other commercial and academic research establishments in approximately 100 countries. Hamilton Thorne Ltd. is headquartered in Beverly, Massachusetts.

View Hamilton Thorne Profile

More Earnings Resources from MarketBeat